An Exploratory Investigation of a Supplement to Enhance Sleep Quality and Quantity
1 other identifier
interventional
64
1 country
1
Brief Summary
This double-blind study will examine the effectiveness of Dream Powder and Dream Powder Extra Strength over a six week period. The main outcomes of interest will be sleep quantity and quality, as well as self-reported changes in sleep across the study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2022
CompletedFirst Submitted
Initial submission to the registry
August 24, 2022
CompletedFirst Posted
Study publicly available on registry
August 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedNovember 8, 2022
November 1, 2022
5 months
August 24, 2022
November 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Perceived Changes in Sleep Quality as reported by questionnaires
Examined across the six week trial with questionnaires. These questionnaires will occur at Baseline, Week 2, Week 4, and Week 6, and will gather information about their ability to fall asleep, stay asleep, and the overall amount of sleep they get on average during the past week.
6 Weeks
Perceived Changes in Sleep Quantity as reported by questionnaires
Examined across the six week trial with questionnaires. These questionnaires will occur at Baseline, Week 2, Week 4, and Week 6, and will gather information about their ability to fall asleep, stay asleep, and the overall amount of sleep they get on average during the past week.
6 weeks
Perceived Changes in Sleep Habits as reported by Questionnaires
Examined across the six week trial with questionnaires. These questionnaires will occur at Baseline, Week 2, Week 4, and Week 6, and will gather information about their ability to fall asleep, stay asleep, and the overall amount of sleep they get on average during the past week.
6 weeks
Participant Perceptions of Sleep
Examined across the six week trial with questionnaires. These questionnaires will occur at Baseline, Week 2, Week 4, and Week 6, and will gather information about their ability to fall asleep, stay asleep, and the overall amount of sleep they get on average during the past week.
6 weeks
Secondary Outcomes (1)
Examine changes in device measured sleep across the six week trial.
6 Weeks
Study Arms (2)
Placebo + Dream Powder
EXPERIMENTALParticipants take the placebo product for two weeks, followed by the Dream Powder intervention product for four weeks.
Placebo + Dream Powder Extra Strength
EXPERIMENTALParticipants take the placebo product for two weeks, followed by the Dream Powder Extra Strength intervention product for four weeks.
Interventions
The Dream Powder and Dream Powder Extra Strength both use nano hemp, reishi, magnesium. L-theanine, and melatonin to promote a healthy sleep pattern
The Dream Powder and Dream Powder Extra Strength both use nano hemp, reishi, magnesium. L-theanine, and melatonin to promote a healthy sleep pattern
The main ingredients in the placebo are: Coconut milk powder, cocoa, cinnamon, monk fruit, natural vanilla flavor
Eligibility Criteria
You may qualify if:
- Self-reported issues with sleep Must be in good overall health with no unstable medical conditions Must own a wearable sleep tracker (i.e., Apple Watch, "FitBit", "Whoop", etc.) Must be willing to discontinue any supplements meant to assist with sleep.
You may not qualify if:
- Females who are pregnant or breastfeeding Diagnosis of insomnia or sleep apnea Taking a prescription medication that affects sleep Anyone with a pre-existing condition that would prevent them from adhering to the protocol Anyone with a known history of past severe allergic reactions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beamlead
- Citruslabscollaborator
Study Sites (1)
Citruslabs
Santa Monica, California, 90404, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Hill, PhD
Citruslabs
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2022
First Posted
August 30, 2022
Study Start
May 9, 2022
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
November 8, 2022
Record last verified: 2022-11